Tech Company Financing Transactions
NanoZymeX Funding Round
Venture Kick participated in a $180 thousand funding round for NanoZymeX. The round was recorded on 3/24/2026.
Transaction Overview
Company Name
Announced On
3/24/2026
Transaction Type
Venture Equity
Amount
$180,000
Round
Undisclosed
Investors
Proceeds Purpose
The funding will help NanoZymeX further develop its lipid nanoparticle technology, conduct additional preclinical studies, and prepare for scalable manufacturing.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Klingelbergstrasse 50
Basel, 4056
Switzerland
Basel, 4056
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
NanoZymeX is a nanobiotechnology startup developing next-generation enzyme replacement therapies using proprietary lipid-based nanoparticles. Originating from research at the University of Basel, NanoZymeX integrates nanotechnology and protein therapeutics to improve intracellular delivery, reduce immune responses, and enable targeted treatment of rare genetic diseases such as Pompe disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Boris Sevarika
Chief Medical Officer
Gianluca di Bari
Chief Scientific Officer
Margarita Dinamarca
Chief Scientific Officer
Eva Hemmrich
Browse more venture capital transactions:
Prev: 3/24/2026: Conduit venture capital transaction
Next: 3/24/2026: EpiFrontier Therapeutics venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs